SIRT2 and neoplasm: As in the melanoma model, Sirt2-KI mice exhibited faster tumor progression in terms of tumor volume (Supplemental Fig. S1B, P = 0.0045, 0.0055, 0.0013, and 0.0001) and final weight (Supplemental Fig. S1C, P = 0.0003).